# Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Oxaliplatin In Patients With Peritoneal Carcinomatosis

> **NCT03172416** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **National University Hospital, Singapore** · enrollment: 21 (estimated)

## Conditions studied

- Peritoneal Carcinomatosis

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** Oxaliplatin & Nivolumab

## Key facts

- **NCT ID:** NCT03172416
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-04-12
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03172416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03172416, "Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Oxaliplatin In Patients With Peritoneal Carcinomatosis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03172416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*